Jasmine Johnson Overcomes Barriers to Build Black Woman-Led Cannabis Company in Florida

Jasmine Johnson, CEO of GÜD Essence, has spent nearly a decade navigating Florida’s challenging medical cannabis licensing system to build one of the state’s few Black woman-led cannabis companies. Despite her extensive background in business, real estate, and hospitality, Johnson’s pursuit of a Medical Marijuana Treatment Center (MMTC) license was fraught with obstacles, including a $150,000 filing fee, a 750-page application, multi-year delays, and a partner withdrawal at a critical moment. "The average entrepreneur cannot sustain a decade-long timeline based on uncertainty," Johnson told High Times, underscoring the immense burden placed on independent operators

Florida’s cannabis equity narrative often focuses on the licensing stage, but Johnson argues that the real difficulties begin after a license is awarded. She points out that the market is skewed toward operators with substantial capital reserves, political influence, and pre-existing infrastructure, leaving minority entrepreneurs at a disadvantage. "Equity is often marketed at the licensing stage," she said, "but the real challenge begins after. There’s a narrative around ‘opportunity,’ but in reality, the market favors operators with deep capital reserves, political relationships and existing infrastructure. Without those, equity becomes more symbolic than functional."

To overcome these hurdles, Johnson leveraged $10.3 million in family real estate equity and structured lease agreements to shift buildout costs to landlords, operating with extreme financial discipline. Unlike larger operators who can afford inefficiencies, every dollar and timeline mattered for GÜD Essence. "Where others can absorb inefficiencies, we’ve had to build with precision. Every dollar, every decision, every timeline matters," she emphasized. The state’s requirement for full vertical integration—mandating cultivation, processing, and retail before any revenue is generated—creates a capital-intensive barrier that disproportionately affects minority and independent entrepreneurs

Johnson has weathered numerous setbacks, including legal delays and partners leaving the project, but remains motivated by a vision of broader access and opportunity. She advocates for reform, suggesting that Florida should reduce entry barriers, allow phased growth instead of mandatory vertical integration, and streamline regulatory processes. "The system underestimates the true cost of entry and survival," Johnson said, calling for a modernized framework that acknowledges the needs of diverse operators and consumers alike. She also highlighted GÜD Essence’s focus on developing clinically targeted products for chronic pain, diabetes, and other health conditions, which go beyond Florida’s current regulatory scope

Despite these challenges, GÜD Essence operates a dispensary in Clearwater, with additional sites planned in Orlando, Jacksonville, and Titusville, and a cultivation and processing campus underway. Johnson stresses that the commitment, time, and capital required to enter and survive in Florida’s cannabis market are far greater than what is publicly discussed. "This is not a market where you can move quickly or test concepts. It requires full commitment upfront, with significant risk and delayed return," she noted. The persistence of entrepreneurs like Johnson illustrates both the potential and the pitfalls of Florida’s evolving medical cannabis landscape

From the OG Lab newsroom perspective, Johnson’s journey highlights the deep structural challenges facing minority and independent cannabis operators in restrictive markets. Her experience underscores the urgent need for regulatory reform and more inclusive pathways for industry participation. As Florida’s medical cannabis sector matures, the success and struggles of companies like GÜD Essence will serve as a bellwether for the industry’s progress toward real equity and innovation